Gaquing, Dolores S.

HRN: 12-76-36  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/01/2026
07/07/2026
IV
500mg
Q6
Colonic CA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: